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  ABSTRACT 
  
 The purpose of this study was to determine the effect of exercise training alone 
and in a model of Type 1 Diabetes Mellitus (T1DM), on Heat Shock Protein (HSP) and 
Nitric Oxide Synthase (NOS) expression in entorhinal adjacent large and small cerebral 
vessels.  Thirty-two rats were randomly allocated to four groups:  control sedentary (C), 
control exercised (CX), diabetic sedentary (D) and diabetic exercised (DX).  Exercise 
training incorporated 5 days/week on a motorized treadmill (27m/min; 6 degree incline; 1 
hour) for 10 weeks. Exercise trained groups had significantly greater Hsp70 expression 
than their respective non-trained groups (p<0.05) and this response was not blunted in 
T1DM animals.  The inducible NOS (iNOS) expression was greater in diabetic sedentary 
when compared to all other groups (p<0.001).  Co-localization of protein with smooth 
muscle cells illustrates that all HSP and NOS signal content is localized to the smooth 
muscle area (SMA). 
 
 
 
 
 
 
 
 
 
 
 
  
Keywords: cerebral vessels, exercise, type 1 diabetes mellitus, Heat shock protein 70, 
inducible nitric oxide synthase 
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CHAPTER 1 
1.1 Introduction 
Exercise is a physiological stressor that partially protects against a multitude of 
biological stressors which impose deleterious consequences on cellular and tissue 
homeostasis.  Hence, exercise interventions are becoming increasingly important as they 
have been illustrated to function as a critical preventative and potential therapeutic tool 
under a variety of conditions.  Indeed, aerobic exercise training is neuroprotective  in an 
assembly of diseases that include but are not limited to brain ischemia tolerance in the 
event of ischemic stroke.   
Strokes are the second leading cause of death worldwide. According to the 
American Heart Association, ischemic stroke accounts for 87% of the incidents while 
hemorrhagic and transient ischemic attacks (TIA) account for the remaining 13% (36, 
62).  Although exercise may limit the likelihood of and/or damage caused by stroke  the 
exact mechanism(s) as to how exercise exerts its benefits is not well understood (14, 16, 
17).  However, the biological networks that elicit exercise-induced protection are 
complex.  However the role of chaperone proteins in cellular stress response has been 
linked to stroke injury protection (42, 56).  
Exercise is a physiological stimulus that elicits a systemic stress response on a 
multitude of molecular regulators (4, 18).   A highly studied family of chaperone proteins 
known as heat shock proteins (HSPs) encompass inducible members that are activated by 
exercise stress such as the 70-kDA HSP (Hsp70) (28).  Minor episodes of stress are 
capable of eliciting this heat shock response (HSR) and thereby conferring protection in 
the event of a major stressful event.  In this regard, exercise pre-conditioning has been 
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found to stimulate the HSR and induce Hsp70, which in turn prevents and rescues 
extensive  protein misfolding thereby building systemic and potentially brain ischemia 
tolerance (81).  Subsequent research in experimental T1DM models hinted at over 
expression-associated neuroprotection protecting and/or curbing the severity of focal and 
global cerebral ischemia (68).  Exercise pre-conditioning increases brain ischemia 
tolerance by inducing the HSR which in return helps improve recovery in diseases that 
are susceptible to protein misfolding and inflammation .   
Ischemic stroke prevalence has increased globally in conjunction with the 
growing Type 1 Diabetes Mellitus (T1DM) epidemic.   Epidemiological studies from the 
American Stroke Association indicate a significantly high risk factor for ischemic stroke 
in patients with T1DM regardless of age and  the process of aging itself, independently 
increases the prevalence of ischemic stroke (23, 62).  T1DM related hyperglycemia may 
cause endothelial dysfunction and accelerated atherosclerosis, notable precursors that 
lead to ischemic stroke. Particularly, the inflammatory consequences and the ensuing 
endothelial dysfunction exhibited in T1DM etiology have been associated with metabolic 
shifts in nitric oxide (NO) and nitric oxide synthase (NOS) regulation (22, 63).   NO 
balance is  critical for cellular function and  is maintained by physiological production of 
NO by eNOS but can reach toxic levels due to the inducible NOS (iNOS) (22, 28, 45).  In 
the T1DM profile, there is a pattern of decreased NO bioactivity with decreased eNOS 
content and in some cases, this observation is concurrent with an overproduction of pro-
inflammatory iNOS (21, 32). In addition to the general protection against protein 
misfolding conferred by Hsp70, this protein was recently shown to elicit an anti-
inflammatory effect through the inhibition of  iNOS (1, 35).  This chapter will provide an 
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overview of the neuroprotective role of exercise pre-conditioning in cerebral health and 
disease, with particular attention to heat shock protein regulation as a potential 
mechanism conferring this protection.  The overview will incorporate a perspective on 
aerobic exercise training and the changes associated with T1DM on brain health with 
emphasis on the Hsp70, Hsp90, iNOS and eNOS and how these respective protein 
expressions are characterized in diabetes alone, and with exercise training interventions. 
1.2 T1DM and the Progression of Cardiac and Vascular Consequences 
 According to the American Diabetes Association (ADA), T1DM although not as 
prevalent as T2DM, remains a growing global concern (7). T1DM is an autoimmune 
disorder caused by the immune mediated destruction of pancreatic β cells, resulting in an 
significant decline in the production of insulin (58). Individuals with T1DM undergo 
exogenous insulin therapy, however, long-term glycemic complications persist and 
fluctuations between hyperglycemic and hypoglycemic states impose distress to daily 
life. The Framingham study report from 1979 on diabetes and cardiovascular implications 
established that patients with diabetes had a high prevalence of peripheral artery disease, 
coronary disease, and strokes (33, 77). Diabetes itself is associated with impaired tissue 
defense mechanisms that render the body vulnerable to various stressors. One such 
stressor is oxidative stress, which potentially plays a significant role in diabetes related 
complications (37).  Hyperglycemia and hypertension are two atherogenic factors 
underlying T1DM macro- and micro- vascular complications that evolve to become 
primary contributors to injurious cardiovascular events, stroke, or peripheral vascular 
disease (52, 58). These atherogenic factors contribute to the development of oxidative 
stress, an imbalance in nitric oxide bioavailability and the production of reactive oxygen 
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species (ROS) that collectively contribute to endothelial dysfunction (ED)  implicated in 
T1DM induced stroke and cardiovascular complications   (52, 58, 63).   
1.3 Histological Perspectives on Cerebrovasculature  
             Blood vessels form an intricate network throughout the central and peripheral 
system.  The innermost layer of blood vessel, the tunica intima or endothelium, is the 
immediate contact to the circulation and behaves as a selective barrier to constituents in 
the blood.   In the case of larger blood vessels, the endothelium is surrounded by a tunica 
media layer of vascular smooth muscle cells (VSMC) that are responsible for 
vasodilation and vasoconstriction (71, 74).  Amongst other methods, the endothelium 
governs vasodilation through nitric oxide synthesis and vasoconstriction through the 
synthesis of endothelin (74).  In peripheral circulation, blood vessels supply tissues with 
nutrients upon cellular demand. Exercise creates an environment of high metabolic 
demand and initiates physiological changes that include fluxes in oxidative stress, sheer 
stress and changes in perfusion pressure that initiate vascular responses in order to divert 
nutrients to the site of working muscles (29).  The central nervous system circulation 
varies from that of peripheral, because the brain requires a more constant blood flow.  
Though exercise-induced vascular responses have been investigated in skeletal muscle 
and myocardial vasculature, very little is known of the mechanisms or components 
underlying molecular changes associated with exercise stress in cerebral vessels. In 
T1DM, progressive metabolic instability leads to structural changes in the vessels and the 
consequences lead to events of ischemic stroke (58). An aspect of therapeutic stroke 
research is targeted towards post-stroke injury and attenuating the degree of injury.  It is 
illustrated that stroke induced inflammatory reactions in the vessel, is on such mechanism 
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underlying prolonged post-stroke injury and evidenced by Kusaka et al. , who illustrated 
underlying causes of prolonged post-stroke injury to a decreased reactivity of cerebral 
arterioles during reperfusion (37).  
 The mammalian brain is sensitive to oxidative stress and this is evident in the 
aged brain.  With aging, significant and progressive increases in the level of oxidative 
stress have been linked to the development of various neurodegenerative conditions such 
as Alzheimer’s disease. Studies with a neurodegernative Alzheimer’s model have 
indicated that the hippocampus and adjacent areas, experience vast changes with aging 
and that they are particularly sensitive to stress due to a high regional concentration of 
glucocorticoid receptors (3, 20).  In recent years Brown et.al established neuronal 
expression of heat shock protein in rat brain, particular to the hippocampus and adjacent 
the entorhinal cortex matter (9).  A recent study has demonstrated a link between the aged 
brain that exhibits the Alzheimer’s phenotype and that of a T1DM brain and have 
postulated a potential glucoregulatory mechanism underlying the progression of 
Alzheimer’s etiology (6).  Similar investigations to the aforementioned 
neurodegenerative models have illustrated neuronal HSR in areas of the mammalian 
cerebrum that were confined to the spinal cord, hippocampus and entorhinal cortex. The 
latter two locales in the rat mid-brain have been the most susceptible to disease induced 
neuronal loss including ischemic stroke (19, 60).  Though tissue specific heat shock has 
been identified in cerebral tissue, very little is known of the cerebrovascular response to 
T1DM.  
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1.4 Physiological Implications of T1DM and Stroke  
There is growing evidence of end-organ injury in the central nervous system that 
has been attributed to hyperglycemia mediated metabolic and endocrine disturbances (7).  
These disruptions lead to structural shifts in vascular morphology and functional shifts in 
cerebral blood flow (CBF), which collectively manifest to progressive atherosclerosis in 
diabetes and may induce stroke (65, 75). The incidence of ischemic stroke is two to six 
folds higher in patients with diabetes when compared to those without diabetes (77).   
Diabetes affects the cerebrovascular circulation by increasing the risk of 
intracranial and extra cranial atherosclerosis (7, 46). In diabetic cerebral 
microvasculature, structural irregularities include decreased capillary density and 
thickening of capillary basement membranes (5, 34). Preliminary data asserts  
microvasculature injury appears to manifest prior to the onset of clinical symptoms, 
however  little else is characterized in the microvasculature to bolster these assertions (7).  
More so than other organs, the brain requires continuous circulating glucose and 
cerebral health is tightly managed by glucoregulatory control.  The brain requires 1/5 of 
the available oxygen uptake at rest for survival and CBF is tightly regulated to ensure 
sufficient nutrient and oxygen delivery (61). In a normotensive state, CBF is relatively 
constant and maintained at arterial blood pressure of 60 to 160mmHg in order to 
circumvent fluctuations in perfusion, that could lead to a state of hypoxia or potentially 
increase in intracranial pressure (55, 61).  Cerebral autoregulation, a marked feature of 
the developed mammalian brain, refers to the capacity of cerebral vessels to compensate 
for and actively adjust any decrease in cerebral perfusion pressure by vasodilatation and 
adjust for increased BP (55, 61) .   
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The more functional disturbances associated with T1DM induced stroke include 
hyperglycemia and hypertension mediated regional alterations in CBF (6, 10, 26). 
Systolic blood pressure is a regulator of CBF and hypertension causes marked adaptive 
changes in the CBF, which lead to increased brain vascular resistance and loss of the 
physiological mechanism of autoregulation observed in T1DM (61, 65). T1DM patients 
that experience hypertension also exhibit altered CBF, in particular an overall chronic 
reduction in CBF   (68).  A chronic reduction of CBF carries increased risk factors for a 
multitude of cerebrovascular diseases and it is clear that an absolute reduction in CBF is a 
high risk factor for susceptibility to stroke (26). Brennan et.al  established that chronic 
hyperglycemia is associated with a reduction in global CBF (gCBF), the same effect 
observed with acute hyperglycemia in animal models (5, 6, 21). Subsequent 
investigations illustrated a more regional alteration in CBF and a linear relationship 
between the degree of hyperglycemia and the decrease in gCBF (53, 70).   
Endothelial dysfunction is an injurious vascular manifestation of hyperglycemia 
and hypertension. The mechanism(s) by which ED arises is initiated by hyperglycemia 
mediated imbalance in NO bioavailability and subsequent accumulation of ROS (58).  
Specifically, toxic production of NO leads to an accumulation of superoxide anion (O2
−
) 
and the subsequent formation of the ROS, peroxynitrite (ONOO
−
) (4, 22, 35).  
Peroxynitrite is a potent oxidant that initiates substrate nitration and protein nitrosylation 
which terminally attenuates the activity of eNOS (4). This reduced eNOS activity further 
renders the vascular environment vulnerable to reduced NO-dependent vascular 
responses and promotes key steps in vascular inflammation during stroke injury, 
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including increased leukocyte adhesion to endothelial cells, recruited platelet aggregation 
and underlying smooth muscle proliferation (58, 65). 
During an ischemic event, inflammatory regulators contribute to and exacerbate 
stroke injury (65).  At the site of focal ischemia, there is an increased aggregation of 
neutrophils, monocytes and transmigration of adhesion molecules, which subsequently 
triggers cytokine signaling and recruits pro-inflammatory cytokines to the site. Cytokine 
signaling recruits tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), interleukin-6 
(IL-6) and iNOS to the ischemic site and elevates the inflammatory response causing 
exacerbated stroke injury. T1DM may exacerbate the sequelae of such ischemic events 
leading to greater brain edema and larger infarct volume (36, 46). 
Perturbations to NO regulation are detrimental to vascular homeostasis, 
particularly endothelial function.  It is known that physical activity enhances endothelial 
function through adaptive changes in NO regulation, particularly through eNOS mediated 
interactions (57).  NO is synthesized by three NOS isoforms that include neuronal 
(nNOS, NOS-1), inducible NOS (iNOS, NOS-2) and endothelial NOS (e-NOS, NOS-3) 
(22) .   NNOS is expressed in specific neurons in the CNS whereas iNOS, primarily 
identified in macrophages, can be stimulated by cytokines in a variety of tissues, 
especially in inflammatory disease (22). ENOS confers vascular protection throughout 
the system via normostatic production NO which then allows the vasculature to carry out 
physiological vasodilation, in optimal and sub-optimal stress conditions (18, 57). A 
baseline level of NO is necessary for optimal vascular function, however toxic levels of 
NO produced by iNOS, shifts the excess NO into a separate biological pathway resulting 
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in an accumulation of superoxide anion and the production of harmful oxidants, such as 
peroxynitrite  (7, 57).   
1.5 Exercise Physiology & Implications in T1DM 
              Physically active organisms have a better tolerance to various stressors when 
compared to their sedentary counterparts, due to a progressive systemic pre-conditioning 
(78).   Exercise is a relatively minor physiological stressor which nonetheless may initiate 
a stress response if the exercise intensity is sufficient (47). This may elicit protective 
downstream adaptations that are cell, condition and system specific (8). These adaptive 
responses are also specific to the exercise modality, intensity and duration (38, 48).  
Aerobic exercise training has been illustrated to be beneficial for reducing all-cause risk 
of premature death in populations highly susceptible to cardiovascular and 
cerebrovascular diseases, including models of aging and  T1DM (2,50,24). Exercise 
preconditioning studies in ischemia-reperfusion models in the myocardium have 
illustrated an exercise-training induced ischemia tolerance, or  attenuation of post-
ischemic consequences (49, 72). Likewise, there has been a progressive movement in 
understanding the endogenous neuroprotective effect underlying brain ischemia tolerance 
in models of ischemic stroke, reperfusion injury and recovery (81). 
  Neurodegenerative therapeutics have suggested a neuroprotective role of higher 
intensity aerobic exercise training  in potentially decreasing the risk, delaying the onset 
and/or alleviating symptoms exhibited in a number of neurodegenerative diseases  (2, 3, 
10, 50, 69).  According to research conducted in which the middle cerebral artery is 
briefly occluded, (MCAO), the extent of cerebral consequence is shown to be directly 
affected by the severity of ischemic insult and by the post-ischemic response, which 
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includes activation of pro-inflammatory cytokines (36, 44).    Kitagawa et al. established 
the phenomena of ‘brain ischemia tolerance’ wherein pre-conditioning events, such high 
intensity exercise, attenuated post-stroke related injury (11, 81). The attenuated stroke 
injury is a result of decreased activation of pro-inflammatory cytokines (such as Il-6 and 
TNFα) and iNOS, in conjunction with an attenuated regional and significantly lowered 
cerebral infarct volume  (17, 41, 81).  Ding et.al have demonstrated an aerobic exercise-
preconditioning induced reduction in cerebral infarct volume and suggest this reduction 
observed can be attributed to vastly improved post-stroke recovery mechanisms (13, 17).  
Focal ischemia is initiated in the larger vessels however the mechanisms of stroke 
induction and exercise-mediated neuroprotection remains unclear and have directed 
current stroke research towards the core of microcirculation and vascular pathobiology.  
Studies with MCAO induced stroke and observations of post-stroke reperfusion hinted at 
the integrity of microcirculation as a determinant of the severity of consequences during 
ischemic reperfusion and recovery (2, 17). Therefore, a further understanding of changes 
in the vasculature would provide closer perspective on the potential mechanisms 
underlying stroke injury and the effect of exercise training.  
Various cerebrovascular diseases are characterized by marked changes in CBF, in 
particular, a reduction of CBF (39, 61, 68). During exercise, the cardiovascular output is 
actively modifying systemic vascular blood flow to working regions, however global 
CBF (gCBF) is known to remain constant despite regional changes in CBF (39). Studies 
assessing middle cerebral flow velocity (MCAv) using pulsed doppler ultrasound, in an 
exercise training model, have illustrated a 10-25% increase in MCAv following exercise 
training in aged adults (53).  It is important to note that aging itself is characterized by 
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chronic reductions in CBF. Consequently this response could be differently affected, in 
which case exercise could bring CBF back to baseline conditions observed prior to the 
onset of aging (55, 65).  Though MCAv is elevated post-training, gCBF remained 
constant and unaffected by exercise in those particular investigations. Ainslie et al. 
demonstrated that there was a change in gCBF when adjusted for varying exercise 
intensities (55). With moderate intensity training, which equates to 60% VO
2max 
, there 
was marked elevation in gCBF (53, 55).  In contrast, with higher intensity exercise where 
VO
2max
>60%, there is a significant decline in gCBF to baseline levels and during that 
window of heavy metabolic demand, it is postulated that transient hyperventilation 
mechanisms take over for short-term metabolic demand (39, 55). The brain strives to 
maintain its autoregulation, in which case high intensity aerobic exercise generally cannot 
be maintained for extended durations. In some models of exercise training and induced 
stroke, exercise-trained animals exhibit higher regional CBF during post-stroke 
reperfusion and thus attenuated injury despite non-significant gCBF increases during 
exercise training. Perhaps this indicates that there may be various physiological 
adaptations of exercise training that contribute to the observed post-stroke protection  
(43).  The exact mechanisms as to how CBF is governed and adapts with exercise 
training remains unclear.   
1.6 Biological Basis of Heat Shock Proteins 
 The exact underlying mechanism(s) as to how exercise imposes ischemia 
tolerance remains unclear, however research has recently been directed to the role of 
stress response adaptations as a possible factor in this regard.  Heat shock proteins (HSP) 
are ‘evolutionarily conserved’ stress proteins that function as molecular chaperones and 
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exhibit a cytoprotectant role during physiological insults, including diseases that incite 
cellular stress. HSPs have also been widely studied for their anti-inflammatory role in 
protection against cytotoxicity. HSPs are classified by their molecular mass, ranging from 
the smaller HSP families such as Hsp27 to the larger HSPs that include  Hsp70, Hsp60 
and Hsp90. HSPs function as constitutive or inducible stress proteins that have 
physiological importance that are condition and tissue specific (56, 76).  The constitutive 
HSPs are generally thought to engage in housekeeping roles while the inducible HSPs are 
up regulated by a stress stimulus for directed cellular protection (56). 
 Under physiological conditions Hsps are primarily located in the cytoplasm and 
bound to heat shock factors (HSFs), of which there are three variant transcription factors 
in mammals (54).  When sufficient physiological stress leads to some protein 
denaturation or damage, dissociation of HSPs from HSF occurs with subsequent nuclear 
localization and stress protein induction occurs (54).    
1.6.1 Molecular Basis of HSPs 
 Within the chaperones, the70-kilodalton (kDA) family of HSPS, Hsp70, has been 
most characterized in exercise health and disease models  (54, 76).  The Hsp70 family of 
proteins encompasses the constitutively expressed protein, Hsc70 (Hsp73), and its more 
widely studied inducible counterpart, Hsp70 also known as Hsp70i and Hsp72 (54).  
Researchers have long established the ubiquitous role of Hsp70 in the maintenance of 
cellular homeostasis. Under normal physiological resting conditions, Hsp70 exists in low 
quantities in most tissues, unlike the constitutive counterpart, Hsc70 (79). The 
physiological benefits of Hsp70 overexpression have been established in a variety of 
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systemic models.  Consequently, heat shock pre-conditioning induced elevations in 
myocardial Hsp70 expression have been observed in conjunction with decreased 
ventricular infarct damage post-ischemia (40, 49).  Further, Hayes et.al noted an 
increased Hsp70 mRNA content was directly correlated with reduced area of cerebral 
infarct following MCAO induced ischemic stroke (12). 
 The constitutively present 90-kDA heat shock protein, Hsp90, accounts for one of 
the most abundant cytosolic proteins (63, 64).  Hsp90 functions as an interactive 
housekeeping protein that ensures the maintenance of protein-folding and aggregation 
and acts as a chaperone to many client proteins  (59). Of particular interest, Hsp90 has 
been demonstrated to interact directly with eNOS and thus mediate the intricate balance 
between NOS, NO and superoxides (18, 69).   Hsp90 primarily behaves as a signal 
transduction molecule. For example, it initiates phosphorylation of eNOS in order to 
regulate vascular permeability and vasodilation (69).  
1.6.2 Physiological Basis of HSPs and Exercise 
 The magnitude and duration of exercise stress plays a critical role in the stress 
induction response such that,   It is evident, the more demanding the exercise, the more 
robust the HSP induction (48). With aerobic training, Harris et.al demonstrated a 
sustained training-induced increase in Hsp70 levels in rodent striated muscle, whereas the 
response was diminished in other Hsps studied.  Data from Milne and Noble, illustrated 
only high-intensity exercise training is sufficient to induce myocardial Hsp70 when 
compared to lower intensity training(49).  Physical activity induction of Hsp70 has not 
been as actively investigated in the brain as systemic tissue, however Campisi et.al 
demonstrated habitual exercise stress does induce a HSR and subsequent Hsp70 response 
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in the various regions of the brain including hypothalamus, hippocampus and prefrontal 
cortex alongside their respective adjacent areas (8).  They postulated that the Hsp70 
response could potentially be neuroprotective given observations from training studies in 
skeletal muscle and myocardium (8) 
 Hsp90 is not as extensively characterized as Hsp70 in exercise training models.  
Atalay et.al has observed no change in Hsp90 expression in vastus lateralis and red 
gastrocnemius following an 8-week aerobic exercise training intervention, which can be 
attributed to the specific type of muscle investigated (25).  Other studies, did note an  
increase in Hsp90 expression in the soleus muscles and vascular increase in eNOS 
expression (25, 66).  These observations are attributed to exercise mediated increases in 
NO to allow for increased flow to working muscles, resulting in increased shear stress on 
vascular wall (24).  Hence, exercise induced changes in Hsp90 may be more associated 
with the vasculature than the skeletal muscle fibers. No knowledge exists in the 
cerebrovascular Hsp90 and eNOS expression following exercise training, however it can 
then be assumed that Hsp90 and eNOS would respond differently in cerebrovasculature 
when compared to skeletal muscle, in order to strictly regulate steady cerebral flow when 
total cardiac output rises.  
1.6.3 Physiological Basis of HSPs and Disease  
 A myriad of biological mechanisms have been under close scrutiny in an effort to 
better understand the exercise mediated ischemic tolerance in stroke recovery (16).  The 
interaction between chaperone proteins HSPs and cellular stress response have been 
fundamental constituents in understanding the pre-conditioning mediated cerebral 
tolerance exhibited in stroke models. 
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 Hsp70 over-expression produces notable physiological benefits in many tissues. 
More recently, it includes potential anti-inflammatory actions regulated by Hsp70.  
Wieten et. al demonstrated Hsp70 up regulation with concurrent inhibition of 
inflammatory cytokines that include TNFα and IL-6 (79, 82).  Recent studies by Weiss 
et.al have established that direct interaction between Hsp70 and an inhibitor of nuclear 
factor kappa-B kinase subunit alpha (IKK-α), interrupts the activation of a master pro-
inflammatory transcription factor nuclear factor kappa-light-chain-enhancer of activated 
B cells (NF-κB) (43, 82).   Co-immunoprecipitation studies by Zheng et.al have 
illustrated an Hsp70 mediated inhibition of NF-κB and associated NF-κB  regulatory 
genes that specifically include pro-inflammatory expression of iNOS (82). .  
 The stress response has a differential impact on constitutive proteins when 
compared to their inducible counterparts.  Variability in Hsp90 expression has been 
implicated in regulation of oxidative stress in pathological conditions such as hypoxia 
and preeclampsia (57, 63).  In T1DM animal models, the progressive hyperglycemic state 
appears to elicit  a dissociation in the Hsp90 interaction with eNOS which has been 
attributed to an increased interaction between Hsp-90-IKKβ and deactivation of eNOS 
(63). In effect, increased Hsp90-IKK interactions allow for subsequent activation of 
NFκB and the ensuing inflammatory and cytokine response while simultaneously 
blunting NO signaling (51).  
1.7 Nitric Oxide Synthase and HSPs 
1.7.1 iNOS and Hsp70  
Type one diabetes is a major risk factor for vascular dysfunction whereby altered 
NO regulation and elevated oxidative stress leads to vascular inflammation and ischemic 
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stroke.  INOS is a pro-inflammatory protein, that upon induction serves as a primary 
inflammatory agent, eliciting the synthesis of toxic levels of NO (35).  Immune reactions 
are mediated in part through activation of NF-κB through physiological stress (including 
ischemia and oxidative stress), leading to an up regulation of downstream pro-
inflammatory genes including iNOS (44). (Fig.1)  Under normal physiological 
conditions, there exists low to no CNS expression of iNOS however during inflammatory 
events, iNOS is induced by cytokines that include TNFα, Interferon gamma (IFNγ) and 
Interleukin-1 beta (IL-1β) (30, 35).  This immunological response is observed and 
exacerbated in T1DM brain, during ischemic stroke (43).  Parmentier et.al demonstrated 
the impact of exogenous administration of iNOS blockers on the reduction of post-
ischemia cerebral infarct volume (44). Ross et.al illustrated a considerable reduction in 
infarct volumes in an iNOS knockout mouse model compared to wild-type animals, when 
subjected to a bout of cerebral ischemia (62).   
Hsp70 is involved in adaptive and innate immune regulation which varies 
according to the location of its induction and expression (82).  Intracellular 
overexpression of Hsp70 in astrocytes has been noted to reduce inflammatory induction 
of toxic levels of NO by iNOS (79).  As mentioned, physiological levels of NO derived 
from eNOS governs normal vasodilation in the system, however toxic levels of NO 
oftentimes 10 times as much as eNOS produced by iNOS, results in peroxynitrite 
formation and free radicals causing heightened oxidative stress.  Hsp70 overexpression 
directs an inhibition of inflammatory responses through deactivation of NF-κB and the 
downstream NF-κB dependent pro-inflammatory component, iNOS (79, 80, 82). In 
effect, Hsp70 elicits protection through inhibition of pro-inflammatory proteins that 
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would otherwise compromise brain health in various conditions of inflammation.  
Induced or transgenic overexpression of Hsp70 correlate to a significant reduction in 
brain infarct volume following ischemic insult (41). The exact mechanism of this 
antagonistic interaction, where an overexpression of Hsp70 is noted with a concurrent 
down regulation of iNOS, is not entirely clear.  Yenari et.al, implemented a transient 
MCAO stroke model in transgenic mice exhibiting Hsp70 overexpression, through which 
the preliminary data illustrated increased Hsp70 association with NF-κB and IκB during 
reperfusion and recovery (79, 80).  This increased association then prevents 
phosphorylation of IκB by IKK and consequently establishes the inhibition of NF-κB (51, 
82). In doing so, Hsp70 overexpression illustrated to regulate the inhibition of NF-κB and 
subsequent downstream inflammatory components. Data from Yenari et.al allude to an 
Hsp70 mediated anti-inflammatory regulation and an inhibition of iNOS, which would 
warrant further characterization of Hsp70 and iNOS in disease conditions that are 
threatened by inflammatory consequences (80, 82).  
1.7.2 eNOS and Hsp90 
 From its discovery, Hsp90 has been established as a regulator of varying signal 
transduction pathways that include interactions with over 200 client proteins and 50 co-
chaperones, making it difficult to characterize its primary role (59). Investigations 
evaluating more specific Hsp90 interaction with cellular constituents provide a better 
understanding of the role of Hsp90 in health and disease. In the latter 1990s, Sessa et.al 
introduced the biological association between Hsp90 and eNOS, whereby his team of 
researchers  demonstrated activation of eNOS upon binding with Hsp90 (63).  In doing 
so, Hsp90 interacts with eNOS and upon interaction Hsp90 is further recruited to the 
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eNOS complex by surrounding molecular agonists (69). Vascular regulation relies on 
eNOS, which governs blood flow, blood pressure and angiogenesis through physiological 
NO production (63, 64).   Exercise training results in elevated systemic vascular eNOS 
expression, localized to endothelium and VSMCs,  in conjunction with increases in 
concentration of NO (67). This is postulated to be due to exercise-induced shifts in 
laminar flow and shear stress on the vasculature, in order to ensure adequate perfusion to 
the working system.   From a T1DM perspective, Mohan et.al illustrated an IKKβ 
interaction with Hsp90 and this interaction is augmented by hyperglycemia in cultured 
vascular endothelial cells, in doing so this diminishes Hsp90 interactions with eNOS (51).  
This diminished interaction is one possible mechanism that illustrates how severe 
hyperglycemia may attenuate eNOS activation and expression, observed in the 
progression of T1DM phenotype. Fig. 1.   
1.8 The T1DM Insulin HSP Connection 
 Individuals with T1DM undergo exogenous insulin therapy, which incorporate 
subcutaneous planted insulin pumps or repeated injections to maintain physiological 
blood glucose concentrations (3). In the brain, insulin levels are governed by the 
endothelial transport across the blood-brain barrier into the cerebrospinal fluid and 
interestingly, the cerebral levels are noted to be independent of plasma insulin, however 
systemic changes in circulating insulin still govern cerebral functions (3).  Acute studies 
noted a short-term insulin withdrawal lead to deleterious neurochemical changes in brain 
and subsequent insulin replacement lead to complete or partial restoration of  cerebral 
function (6).  Notably, T1DM is a condition that is initiated through an autoimmune 
targeted elimination of pancreatic beta cells and or circulating insulin (3).  Investigations 
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using bacterial Hsp70 orthologs hint at the depletion of Hsp70 as possible mechanism to 
the observed increase in epitope recognition by T cells and subsequent acceleration in the 
immune-mediated progression of T1DM (73). With studies investigating diabetic 
peripheral neuropathy (DPN) it is then postulated co-administration of other diabetic 
treatment including heat shock inducers maybe perhaps improve or attenuate the 
progression of DPN (73). Studies by Li.et al have illustrated an insulin mediated 
induction of low-level vascular Hsp70 expression alluding to a possible shared signaling 
pathway between Hsp70 and insulin (40). 
1.9 Summary  
T1DM is a risk factor for stroke, of which ischemic stroke accounts for 80-85% of 
stroke incidence. Hyperglycemia mediated metabolic shifts such as an increase in 
oxidative stress in the microcirculation, have been implicated as a mechanism by which 
diabetes contributes to a significant increase in the risk for vascular dysfunction in the 
brain. Epidemiological studies with exercise pre-conditioning in humans, have illustrated 
increased brain ischemia tolerance correlated to a decrease in post-stroke injury and/or 
the potential to decrease the prevalence of ischemic stroke. It has been illustrated that 
exercise preconditioning stress confers neuroprotection from ischemic stress in 
conjunction with an increased tissue HSP induction.  Of particular interest, Hsp70 
overexpression has been attributed to the neuroprotection in conditions of both focal and 
global ischemia. This overexpression of Hsp70 has been attributed to increased brain 
ischemia tolerance and has also been linked to anti-inflammatory role, specifically an 
Hsp70 mediated inhibition of NF-κB and iNOS.  In models of health and disease, the 
function of housekeeping regulation is oftentimes overlooked due to their highly 
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regulated constitutive nature. However it is important to elucidate the interactions of 
housekeeping proteins with secondary components.  Hsp90 interactions with eNOS 
highlight the potential importance of protein-interactions in disease, explicitly the 
progression of diabetes induced vascular dysfunction. Diabetes induced endothelial 
dysfunction has been linked a decreased expression of eNOS and exercise training has 
differentially affected this response in systemic tissues.  Patients with T1DM, despite 
exogenous insulin therapy, still experience progressive microcirculatory insults from 
metabolic glycemic shifts. Pharmacological HSR inducers have recently become a 
potential therapeutic thought however very little is still known of the cerebral heat shock 
response and the characterization of diabetic stress in cerebrovasculature.  Exercise 
training remains a viable potential therapeutic strategy for diabetes induced 
cerebrovascular complications.   Thus the objective of this study is to primarily evaluate 
the effect of 10-weeks of high intensity aerobic training alone and in controlled to slight 
hyperglycemic T1DM condition, on HSP and NOS expression in large and small cerebral 
vessels. The co-localization of Hsp70, Hsp90, iNOS and eNOS proteins with vascular 
smooth muscle cells, will in addition help elucidate morphological characterization of the 
proteins of interest in cerebral vessels.  It is hypothesized that a 10-week high intensity 
training protocol will be associated with a long-term robust increase in Hsp70 expression 
and T1DM could potentially blunt this training response observed in the trained only 
group.  Secondly, it is hypothesized that following diabetes induction with no exercise 
training intervention, there will be an increase in iNOS expression in the sedentary 
T1DM group.  Lastly, it is hypothesized that exercise training will be associated with a 
21 
 
  
relative increase in Hsp90 and eNOS expression, when compared to the non-trained 
groups.  
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Fig.1.1 Nitric Oxide Regulation in Diabetes 
 
Green dashed encapsulation highlights eNOS bioactivity on endothelial dysfunction.  
Yellow dashed encapsulation highlights NF-κB bioactivity with the downstream regulation of iNOS, 
and how it all collectively contributes to the development of vascular inflammation.  
Visual representation of the anti-inflammatory contributions of Hsp70 overexpression, through 
inhibition of iNOS. 
Figure adapted from Paneni et.al.2013(58) 
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CHAPTER 2 
 
2.1 Introduction 
Strokes are the second leading cause of death worldwide and ischemic stroke 
accounts for over 80% of the incidents (9). Epidemiological studies confirm a high risk 
for ischemic stroke in patients with Type 1 Diabetes Mellitus (T1DM)  (11, 31).  T1DM 
is an autoimmune disorder caused by the immune mediated destruction of pancreatic β 
cells, resulting in an absolute decline in the production of insulin and in increased level of 
circulating glucose (36). Hyperglycemia is a major atherogenic factor underlying the 
macro- and microvascular complications of  Type 1 diabetes that evolve to become 
primary contributors to injurious cardiovascular events, stroke, or peripheral vascular 
disease (28, 30). The majority of ischemic stroke incidents are a terminal causality of 
endothelial dysfunction and accelerated atherosclerosis (17, 42). 
Aerobic exercise is a physiological stressor, established as a preventative tool in 
reducing risk factors for cardiovascular and cerebrovascular complications (7, 36).  
Aerobic exercise training has been attributed to the neuroprotective phenomena of ‘brain 
ischemia tolerance’ (38).  It is suggested that pre-conditioning exercise stress builds an 
adaptive tolerance in the brain by strengthening the recovery response post-ischemic 
event and in effect attenuating the degree of cerebral damage observed (2, 38).  
Exercise functions as a physiological stimulus which elicits a systemic stress 
response that includes the heat shock response (HSR). This response has a  downstream 
impact  on a hierarchy of molecular regulators, such as heat shock proteins (HSPs) (12, 
29).  HSPs are a family of chaperone proteins that are constitutively present and stress 
inducible and which function as tissue-specific cytoprotectants against various 
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pathological conditions. The inducible 70kDA HSP (Hsp70), is a stress induced 
molecular chaperone that offers cardioprotection and is up-regulated with exercise (22, 
26, 27).   Recently, these protective Hsp70 proteins have been found to increase in 
skeletal muscle vasculature following exercise where they likely reduce oxidative stress 
and protect endothelial integrity and vascular signaling (6, 26). In the brain, increased 
Hsp70 tissue mRNA correlates to a reduced area of brain death, observed in a middle 
cerebral artery occlusion (MCAO) stroke model (14, 20).   Studies  in T1DM models, 
hint at HSP associated neuroprotection against severe ischemic strokes whereby 
overexpression of Hsp70 has been noted to curb the severity of focal and global cerebral 
ischemia via attenuated post-stroke infarct volume (37, 39). In an experimental T1DM 
model, Lappalainen et.al recently illustrated a blunted Hsp70 response in whole brain 
tissue lysates following chronic exercise training in diabetic trained when compared to 
non-diabetic trained (20). The distribution and up-regulation of Hsp70 in cerebral 
vasculature is less clear, particularly following training and in chronic disease conditions 
such as diabetes.  
Hsp70 functions as part of a multi-chaperone complex with co-chaperones, such 
as the 90kDA HSP(Hsp90). Hsp90 is a constitutively present cytosolic protein that 
promotes the vasodilation of blood vessels via interactions contributing to the 
phosphorylation of endothelial nitric oxide synthase (eNOS), which produces nitric oxide 
(NO) to increase vascular permeability and promote vasodilation (13, 33).  In a resting 
state, Hsp90 is associated with eNOS. Upon stimulus of the cells from varying stressors 
such as hormones, shear stress or statins, the association between the two proteins 
increases, resulting in physiological NO production (13, 23).  One of the hallmarks of 
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Type I diabetes is reduced vascular function (5).  However, it is unknown whether 
changes in Hsp90 in the cerebral vasculature are negatively affected by diabetes.  The 
influence of exercise training on this protein in cerebral vasculature has not been 
examined either (25).  Previous studies, with chronic and acute aerobic training, noted an 
increase in Hsp90 expression in the soleus muscles and vascular increases in eNOS 
expression (25, 66).  These observations suggest exercise mediated increases in NO to 
allow for increased flow to working tissues (13, 21). Given the differing blood flow 
changes that occur with exercise in the vasculature of skeletal muscle versus the brain, 
the response of Hsp90 and eNOS to exercise training in the latter is unclear.     
Endothelial dysfunction (ED) exhibited in T1DM has been linked with an 
imbalance in NO content and concurrent shifts in nitric oxide synthase (NOS) regulation 
(15, 16).  The NO balance is critical for cellular function and is maintained by 
physiological production of NO by eNOS (10, 32).  The onset of NO imbalance can be 
attributed to toxic over-production of NO, by inducible NOS (iNOS) in which case iNOS 
produces 10 times as much NO as eNOS derived NO.  This overproduction stimulates 
inflammatory cascades and shunts the excessive NO towards the formation of superoxide 
anion (O2−) and the accumulation of the reactive oxygen species (ROS) and peroxynitrite 
(ONOO−).  Peroxynitrite is a potent oxidant which initiates substrate nitration and 
protein nitrosylation and terminally attenuates the activity of eNOS (4, 32). In T1DM 
there is a decreased bioactivity of eNOS and in particular cases, that response is coupled 
with an increase in iNOS bioactivity (1, 32). Mohan et.al demonstrated that Hsp90 
interacts with an inhibitor of NF-κB, IκB kinase β (IKKβ) and that this interaction, which 
is augmented by hyperglycemia in cultured vascular endothelial cells, diminishes Hsp90 
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interactions with eNOS (31).  This diminished interaction between eNOS and Hsp90 is 
one possible mechanism that explains the decreased eNOS bioactivity in T1DM.  This 
reduction may render the vascular environment vulnerable to reduced NO-dependent 
vascular responses and promotes vascular inflammation during stroke injury(34). 
Potential mechanisms underlying improved post-stroke recovery have been 
attributed to exercise preconditioning mediated inhibition of pro-inflammatory factors 
including tumor necrosis factor alpha (TNFα), nuclear factor κ B (NF-κB) and iNOS(8).  
The overexpression of Hsp70 has been attributed an anti-inflammatory role, specifically 
an Hsp70 mediated inhibition of NF-κB  and its downstream factor, iNOS(1, 18, 40).   
The purpose of this study is to evaluate the effect of 10-weeks of high intensity 
aerobic training alone and in a controlled slight hyperglycemic T1DM condition, on HSP 
and NOS expression in large and small cerebral vessels. The method evaluating the 
hypothesis requires independent localization of Hsp70, Hsp90, iNOS and eNOS proteins; 
thus the study will elucidate morphological localization of the proteins of interest in 
cerebral vessels.  It is hypothesized that a 10-week high intensity training protocol will be 
associated with a significant increase in Hsp70 expression and T1DM could potentially 
blunt this training response observed in the trained only group.  Secondly, it is 
hypothesized that, following diabetes,  there will be an increase in iNOS expression in the 
sedentary T1DM group.  Lastly, it is hypothesized that exercise training will be 
associated with a relative increase in Hsp90 and eNOS expression, when compared to the 
non-trained groups.  
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The findings of this study has the potential to direct further attention to the  
exercise induced vascular protection that can be translated into interventions in chronic 
diseases that include components of cerebral vascular pathology, such as T1DM.   
2.2 Methods 
Ethics approval         
This study was approved by the Research Ethics Board of the University of 
Western Ontario, which is in accordance with the guidelines of the Canadian Council on 
Animal Care (Appendix B.1). 
Animals          
Sixty-four, 8-week old, male Sprague-Dawley rats were obtained from Charles 
River Laboratories (St. Constant, QC, Canada).  The animals were housed as cage pairs, 
sustained on a 12-hour dark/light cycle at a constant temperature (20 ±1°C) and relative 
humidity (50%) throughout the entirety of the experiment. All of the animals were 
allowed access to standard rat chow and water ad libitum. 
Experimental Groups   
The rats were randomly divided into one of four treatment groups of eight animals 
each.  The resulting groups are the following:  control sedentary (C; n=8), control 
exercised (CX; n=8), diabetic sedentary (D; n=8) and diabetic exercised (DX; n=8). 
(Figure 2.1) 
 
 
35 
 
 
Experimental Procedures 
Diabetes Induction and Insulin Implantation 
To enable a more translational approach to studying T1DM, a recently established 
model of controlled slight hyperglycemia with insulin was employed for this study (25).  
This particular methodology incorporated multiple low-dose streptozotocin (STZ) 
treatment for the immune induction of diabetes (35) with a clamping of blood glucose 
levels to between 9 and 15mmol/L blood glucose  (Appendix A1, A2).  The multiple low-
dose STZ induction of diabetes consisted of 5 consecutive days of intraperitoneal 
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injections of STZ (20mg/kg), which was dissolved in a cocktail of citrate buffer (0.1M, 
pH 4.5). The insulin therapy was provided by subcutaneous implantation of exogenous 
insulin pellets (1 pellet; 2U insulin/day; Linplant, Linshin Canada, Inc., Toronto, Ontario, 
Canada) (Appendix A2). 
The disease state was confirmed with two measures of non-fasted blood glucose 
(BG) ≥18mmol/L, following the 5-day induction of STZ.  Subsequent injections were 
conducted until the diabetic state was confirmed.  
 
Insulin Dosage   
The state of slight hyperglycemia (non-fasting BG 9-15mM range) in D and DX 
animals was maintained throughout the study with insulin pellet adjustments. (Appendix 
A2). 
  Following the completion of study, the dosage of insulin was measured by 
multiplying the total number of pellets implanted by the units of insulin secreted per 
pellet.  The resulting measure was then individually divided by the animal’s body weight 
to obtain the relative circulating insulin dosage. 
Aerobic Exercise Training Protocol 
Exercise training began 2 weeks after induction of diabetes in the diabetic animals 
and at an age-matched time point for their sedentary controls. Rats were familiarized on a 
motor-driven treadmill, the week prior to the onset of their 10-week training protocol. 
The familiarization protocol consisted of 15 m/min for 5 minutes, 21 m/min for 5 minutes 
and 27 m/min for 5 minutes. Puffs of air and tactile stimulation were used to encourage 
the animals to run.  The 10-week training regimen incorporated 60 minutes of running, 5 
days a week and at exercise speeds of 27 meters per minute at a 6° incline. The intensity 
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of the aerobic exercise, 27m/min was pre-determined to represent higher intensity aerobic   
at approximately 70%-75% VO2max  (35).  
 
Experimental Measures 
 
Body Weights, Blood Glucose, Blood Pressures 
Body weights (BW) and blood glucose concentrations (BG) were measured at 
week 1, week 6 and week 10 of the training period. Blood (approximately 50 ul drop) 
was collected from the saphenous vein and blood glucose concentration assessed via the 
Freestyle Lite Blood Glucose Monitoring System (Abbott Diabetes Care Inc., 
Mississauga, Ontario, Canada).   
Exercise Temperatures  
 For the two groups of animals that underwent exercise-training, CX and DX, pre- 
and post-exercise rectal temperatures were taken at mid-point (Week 6) of training and at 
the endpoint (Week 10).  Additionally, endpoint rectal temperatures were collected from 
sedentary groups, C and D.  
Tissue Collection 
 
At the end of the experimental period animals were anesthetized with urethane α- 
chloralose and euthanized by exsanguination.  Exercise-trained animals were anesthetized 
72 hours following their last exercise session in order to avoid any acute exercise changes 
in tissue morphology.  Whole brains were extracted from the cranial cavity, placed in 4% 
paraformaldehyde (PFA) (Fischer Scientific, Corp.), which was renewed daily for 3 days 
and then placed in 70% ethanol for temporary storage. 
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Tissue Processing  
Prior to fluorescence immunohistochemistry, whole fixed brains were split 
transversely and embedded in paraffin. The paraffin blocks were transversely cut in serial 
10µm thick sections using a microtome (Microm HM33E, Leica). (Appendix A3) 
Sections were mounted on frosted, poly-L-Lysine-coated, positively charged microscope 
slides (VWR® Superfrost® Plus Micro Slide 48311-703, 25x75mm) and stored at room 
temperature for Hematoxylin & Eosin (H & E) and fluorescence immunohistochemistry.  
Each slide held two serial sections of the tissue in order to have negative controls.  
Histochemical Stains 
 
The vascular targets in this study included superior cerebellar vessels adjacent to 
the entorhinal cortex.  In order to observe and confirm histological structures of interest, 
sections were deparaffinised (Leica autostainer XL) and stained with a hematoxylin 
(H&E) protocol using a Leica autostainer XL (Leica ST5010).  (Appendix A4) 
 
In order to observe vessels versus adjacent nerve matter, sections were 
deparaffinised and stained with Luxol fast blue overnight at 58°C, dehydrated in 95% and 
100% clear alcohol, followed by two changes in xylene and cover slipped.  (Appendix 
A4)  
Fluorescence Immunohistochemistry (IHC) 
 As per Maddahi et.al (24) sections were further analyzed using a 2-day, 
immunohistochemical protocol.    
 Day 1: Sections were deparaffinised on the autostainer and antigen retrieved for 2 
hours (Pick Cell 2100 with sodium citrate buffer [10mM sodium citrate, 0.05% tween-20, 
pH 6.0]), following which the slides were transferred to glass coplin jars filled with 
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phosphate buffered saline (PBS, 1M). Slides were then dried with Kimwipe and 
individual tissue sections on the slide were circled with a grease pen (Calbiochem 
ImmunoPen™, EMD Biosciences) and placed in humidity chambers. Slides were 
blocked at room temperature with 10% goat serum in PBS for 1 hour.  In the meantime, 
primary antibodies were thawed at room temperature and assembled as cocktail dilutions  
in 1% Tween-PBS (TPBS) goat serum, which allowed for co-localization of VSMC with  
proteins of interest, Hsp70, Hsp90, iNOS and eNOS. The primary antibodies were 
combined as follows: 
Concentrations and combinations are detailed in Table 2.1: 
 
Table 2.1: Antibody Dilutions  
1° Antibody 
Cocktails 
Antibody Identifier Antibody Concentration 
Hsp70 + Smooth 
Actin 
Hsp70 (SPA-812) 1:100 
Smooth α actin (AB18147) 1:400 
Hsp90 + Smooth 
Actin 
Hsp90 (AB13485) 1:400 
Smooth α actin (AB18147) 1:400 
iNOS + Smooth Actin iNOS (AB 15323) 1:100 
Smooth α actin (AB18147) 1:400 
eNOS + Smooth 
Actin 
eNOS 1:100 (BD610299) 1:100 
Smooth α actin (AB18147) 1:400 
 
Following blocking, slides were washed in PBS for three cycles of 5 minute increments 
and dried with Kimwipes.  One out of two possible tissue sections on every slide were 
incubated with primary antibodies overnight at 4°celsius. The remaining section was 
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incubated with 1% TPBS goat serum in the absence of primary antibodies in order to 
function as a negative control to test for non-specific staining. 
 Day 2: The slides were washed in PBS for three cycles of 5 minute increments 
and dried with Kimwipes, following which all sections were incubated with a cocktail of 
secondary antibodies for 1 hour at room temperature.  
         Secondary Antibody Cocktail: Anti-mouse (Alexa Fluor®488 Goat Anti-Mouse 
IgG, Invitrogen, 1:400) and anti-rabbit secondary (Alexa Fluor®594 Goat Anti-Rabbit 
IgG, Invitrogen, 1:400) antibodies in 1% goat serum in T-PBS. 
 Following secondary incubation slides were washed in PBS for three cycles of 5 
minute increments and dried with Kimwipes.  For the purpose of fluorescent imaging, 
slides were mounted with a fluorescent mounting medium (Prolong® Gold Antifade 
Reagent containing DAPI, Invitrogen) containing 1% 4’, 6-diamidino-2-phenylindole 
(DAPI), a fluorescent nuclear stain and then covered with glass cover slips (VWR® 
SuperSlips™ Micro Cover Glasses, Rectangular, No. 1, 24 X 55mm, CA48382-128). In 
order to maintain the fluorescent signal integrity and minimize photo bleaching, the slides 
were stored in a slide folder at 4˚C until imaging. (Appendix A6) 
 
Fluorescent Microscopy and Protein Abundance Acquisition   
 
The fluorescent bright field microscopy was carried out on a Zeiss Axiovert S100  
microscope and images were captured at 16X and 40X magnification, using Northern 
Eclipse 6.0 (Empix Imaging Inc) software.  The protein content/abundance signal for 
Hsp70, Hsp90, iNOS and eNOS were extracted using Image J (NIH). Specifically, 
protein content was determined by outlining the wall of the blood vessel of interest and 
calculating the integrated pixel density (signal) (Appendix A7) and the same technique 
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was used to determine the integrated pixel density for the negative control of the same 
blood vessel. To obtain the relative protein density, the pixel density of the negative 
control was subtracted from the pixel density of the experimental sample. The difference 
in pixel density provided values that were used to indicate fluorescence signal intensity 
and thus expression of protein. For the collection of data for both small and large vessels, 
this procedure was repeated for four blood vessels from the same animal and averaged to 
give a single value for the particular animal.  
 
Smooth Muscle Area Calculations 
 
For comparative analysis of vessel size and protein content, smooth muscle area 
(SMA) was calculated for each vessel for which the protein content was calculated. These 
SMA calculations allowed for protein content adjusted to the area. For SMA calculations, 
two full length perpendicular diameters from the outer perimeter of each vessel were 
averaged to obtain a diameter for the outer circle.  Likewise, two perpendicular diameters 
from the inner ‘endothelial’ perimeter of each vessel were averaged to obtain a diameter 
for the inner circle. The area of the smaller circle area was then subtracted from that of 
the larger circle in order to obtain the SMA for that specific vessel. (Appendix A8) 
 
Data Analysis  
 
 For all statistical findings, the reports were performed using Sigma.Plot 11 (Systat 
Software Inc.) statistical software.  Body weight, blood glucose concentrations, arterial 
blood pressures and insulin dosage values were compared across all groups using a two-
way repeated measures analysis of variance (ANOVA).  Rectal temperatures across the 
exercise-trained groups were compared using a two-way ANOVA. Where necessary, 
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comparative pairwise analysis was performed using either Tukey’s or Dunn’s post-hoc 
test with significance set at p<0.05. Protein signal content data (expression) from 
fluorescent IHC, unadjusted or adjusted for SMA, were compared using a three-way 
ANOVA across all four groups. Where necessary, comparative pairwise analysis was 
performed using Fischer’s post-hoc test with significance set at p<0.05. A three-way 
ANOVA was performed to evaluate the protein content with respect to potential 
interactions between disease, exercise training and vessel size.  
 
2.3 Results 
Baseline Conditions 
Body Weights: Over the course of the study, all animals across the groups gained 
a significant amount of weight (p<0.05).  Compared to diabetic sedentary (D) and 
diabetic exercised groups (DX), the control sedentary(C) and control exercised groups 
(CX) had significantly greater body weights by the end of week 10 (p<0.05). There was 
no significant effect of exercise on body weight. (Table 2.2)  
Blood Glucose:  Weekly blood glucose concentrations for diabetic groups, D and 
DX post-diabetes induction, were significantly higher when compared to both control 
groups, C and CX (p<0.05). There was no significant effect of exercise on blood glucose 
concentrations. (Table 2.2) 
Insulin Dosage: Total insulin dosage comparison within diabetic sedentary and 
diabetic trained groups, D and DX, suggests that there was pattern of decreased 
exogenous insulin dosage in DX however,  the difference was not significant (p=0.061).   
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Exercise temperatures: In the control exercised group (CX), post-exercise 
temperatures were significantly elevated when compared to pre-exercise temperatures, in 
both week 6 and week 10 measures (p< 0.001). (Table 2.3) 
Effect of Diabetes and Training on Protein Signal Content & Localization 
Visualization of large cerebral vessels and protein signal density in the cerebral 
cortex is demonstrated across Control (C), Control Exercise (CX), Diabetic Sedentary 
(D) and Diabetic Exercised (DX) groups (Plates 1,3,5,7).  In addition, the double 
immunofluorescence was conducted in order to achieve co-localization of protein to 
VSMCs across all groups. (Plate 2,4,6,8) 
Hsp70: Overlay of protein to VSMCs illustrates Hsp70 signal density is primarily 
localized to the SMA. (Plate 1,2) There is a main effect of training on Hsp70 expression 
(p<0.05).  The signal content was greater in larger vessels when compared to small 
vessels. (Fig.2.2) When adjusted for SMA, there is still a main effect of training on 
Hsp70 expression (p<0.001). (Fig.2.3) 
            Hsp90: Overlay of protein to VSMCs illustrates Hsp90 signal density is primarily 
localized to the SMA. (Plate 3,4)  There is no main effect of exercise in the Hsp90 
expression (p>0.05).  The signal content was greater in larger vessels when compared to 
small vessels. (Fig. 2.4) There is a main effect of vessel size (p<0.05).  When adjusted for 
SMA, there is still no main effect of training on Hsp90 expression (p>0.05).  (Fig. 2.5)   
iNOS: Overlay of protein to VSMCs illustrates iNOS signal density is primarily 
localized to the SMA. (Plate 5, 6)  There was a main effect of disease and training on 
iNOS expression (p<0.05). The signal content was greater in larger vessels when 
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compared to small vessels (Fig2.6).  When adjusted for SMA, there is still a main effect 
training and disease on iNOS expression (p<0.001).  (Fig 2.7) 
 eNOS: Overlay of protein to VSMCs illustrates eNOS signal density is primarily 
localized to the SMA. (Plate 7,8) There is no main effect of exercise in the eNOS 
expression (p>0.05).  The signal content was greater in larger vessels when compared to 
small vessels (Fig 2.8). There is a main effect of vessel size (p<0.001). When adjusted for 
SMA, there is still no main effect of training on eNOS expression (p>0.05).  (Fig. 2.9) 
 
Effect of Diabetes and Training on Smooth Muscle Area  
 Because vascular dysfunction may be associated with intima hypertrophy we 
examined the SMA in large and small cerebral vessels across the experimental 
conditions.  There were significant differences in SMA when comparing small versus 
larger cerebral vessels (Fig 2.10; p<0.001), however there were no significant differences 
in SMA between groups (Fig 2.10; p>0.05).  
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Table 2.2. Baseline Body Weights, Blood glucose concentration and Insulin Dosage across control sedentary, control  
exercised, diabetic sedentary and diabetic exercised groups. 
 
 
 
 
 
 
 
 
 
 
 
Values are mean (N=8) ± SD.  BW: * indicates D, DX had significantly lower weights than C,CX (p<0.05) BG:Ϯ indicates D,DX  
post-diabetes induction, had significantly higher BG than C,CX (p<0.05) Insulin Dose: non-significance p=0.061  
Groups Body Weights 
(Kg) 
Blood Glucose Concentrations (mm) Insulin Dose 
Dose/kg 
  
Week  
1 
 
Week 
 6 
 
Week  
10 
 
Week  
1 
 
Week 
 6 
 
Week  
10 
 
 
 
 
 
Sedentary Control 
(C) 
381±20 486±40 546±48 4.5±0.38 4.6±0.45 4.0±0.40 
Control Exercised 
(CX) 
354±24 
 
447±28 
 
510±36 4.26±0.27 4.0±0.45 3.9±0.34 
Sedentary Diabetic 
(D) 
302±21* 422±25* 455±33* 10.8±3.4Ϯ 15.5±2.4 Ϯ 16.8±2.6 Ϯ 5.56±1.5 
Diabetic 
Exercised (DX) 
307±26* 408±3* 
 
429±21* 10.8±5.6 Ϯ 14.8±2.0 Ϯ 13.5±4.6 Ϯ 3.25±1.9 
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2.4 Discussion 
 Ischemic stroke is often a result of endothelial dysfunction and accelerated 
atherosclerosis, conditions attributed to prolonged hyperglycemic exposure exhibited in 
T1DM (21).  Aerobic exercise training has been proven to elicit adaptive neuroprotection, 
particularly through reduced brain injury, demonstrated in in vivo models of ischemic 
stroke (12, 14). A heat shock response (HSR)-induced, anti-inflammatory mechanism has 
been suggested as an underlying this neuroprotection  (8, 9). Nevertheless, the biological 
underpinnings of aerobic exercise training and HSP-mediated effect on the 
cerebrovasculature are not well known, especially in chronic disease conditions such as 
T1DM.  Hence the purpose of this study was to evaluate the effect of 10-weeks of high 
intensity aerobic training in a slight hyperglycemic T1DM condition, on vascular HSP 
and NOS expression. The working hypothesis fittingly afforded the morphological 
localization of these proteins in cerebral vessels following exercise. 
 Fluorescent co-localization of protein overlaid with VSMCs illustrates that the 
Hsp70, Hsp90, iNOS and eNOS expression is primarily localized to the SMA.  These 
observations are similar to those of Kim et.al (26), whereby heat shock stress induced 
Hsp70 expression in mice aortic vascular smooth muscle cells. Through co-association 
and localization of Hsp90 in the mesenteric tissue, Sessa et.al (40,41) determined Hsp90 
is primarily localized to vascular smooth muscle cells as well (46, 47).   The present 
study suggests that the vascular localization of HSPs in cerebral vessels is similar to those 
in the systemic vasculature.  For iNOS and particularly eNOS signal content, though the 
signal is primarily localized to SMA there may be a tendency towards vascular 
endothelial expression though this study does not confirm this assumption.  The 
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observations of this study are in line with a study by Sun et al. (43) which evaluated the 
effects of different exercise modalities on vascular localization of eNOS and iNOS  in the 
murine aorta (50). Their study confirmed endothelial and primarily perivascular 
(surrounding smooth muscle) localization of eNOS and iNOS in endurance trained rat 
aortic sections.  
 At a first glance, these results illustrate the capacity for cerebral blood vessels to 
induce a HSR.  This is the first study to examine the expression and localization of HSPs 
in cerebral vessels. Previous studies have demonstrated Hsp70 induction in brain tissues 
with chronic exercise training but this is the first study to demonstrate a cerebrovascular 
localization of Hsp70 following aerobic high intensity training  (3,27).  Ten-week, high 
intensity training alone (CX) and in T1DM rats (DX), induced a significant Hsp70 
expression  in both small and large vessels when compared to their respective non-trained 
groups(C, D). The training induced Hsp70 expression was not blunted in the controlled 
slight hyperglycemic, insulin treated T1DM model that we employed.  These results are 
in contrast to a previous rat diabetic model that illustrated a blunted training effect on 
whole brain Hsp70 protein content (28).  However, it should be noted that the previous 
study sustained diabetes at a higher grade of hyperglycemia (>20mmol/L), in the absence 
of exogenous insulin when compared to slight hyperglycemic model used in the present 
study (9-15mmol/L). The presence of insulin appears to greatly affect the response of the 
animals for a variety of measures (34).  For instance, Li.et al. (24) have illustrated an 
insulin mediated induction of Hsp70 expression in myocardial tissue.   Thus, the Hsp70 
expression observed in trained diabetic animals could be a synergistic effect of lower 
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grade hyperglycemia maintained in this study and insulin mediated low-level induction of 
Hsp70.  
 In the present study, both Hsp90 and eNOS expression remained constant in 
trained (CX, DX) and untrained (C, D) groups, across both small and large cerebral 
vessels. This observation is interesting in that, prior investigations have illustrated an 
increase in skeletal muscle Hsp90 and eNOS protein content to facilitate an increase in 
blood flow to working muscle (4,7).  Yamaguchi et al. also noted that whole brain Hsp90 
content remained unchanged in from the control to the diabetic state however there is no 
clear interpretation of this result (44). To our knowledge, this study is the first to 
investigate the vascular Hsp90 expression in the brain from exercise trained animals. The 
brain is a unique organ that tightly regulates its vasodilatory mechanisms which may in 
part explain the unaltered expression of Hsp90 across varying conditions.   In the 
normotensive state, Hsp90 is associated with eNOS, and upon stimulation by various 
factors, including exercise, the association between the two proteins increases, resulting 
in baseline NO production which in turn, promotes vasodilation (15, 51). In the brain, 
CBF is tightly autoregulated, unlike in skeletal muscle where there are large variations in 
blood flow that occur in response to exercise (40, 42).  Moderate intensity training, 60% 
VO2max, induces a marked elevation in global CBF (gCBF) during exercise. In contrast, 
with high intensity training (VO2max >60%), there is a significant decline in gCBF to 
baseline level during exercise, despite a significant increase in metabolic demand.  It is 
then postulated that short-term hyperventilation sustains cerebral function under these 
circumstances (42).  It can then be suggested that in our study with higher intensity 
exercise in the brain, there were no significant differences in vascular Hsp90 and eNOS 
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protein content across all groups (C,CX,D,DX) conceivably due to an intrinsically tight 
autoregulation that strives to keep vasodilatory mechanisms as constant as possible.   
 In this study the cerebrovascular iNOS protein content in sedentary diabetic 
animals (D) was significantly greater than all other groups, in both small and large 
vessels. These data agree with studies that have illustrated cerebrovascular iNOS up 
regulation during pro-inflammatory events that include cerebral ischemia, and this up 
regulation is site specific to the cortical region of ischemia in acutely stressed rats (33, 
57).   Since it has been reported (33) that iNOS is not present in the CNS under normal 
conditions, this observation identifies a propensity towards cerebrovascular inflammation 
even in moderate insulin treated hyperglycemic conditions. The most intriguing result is 
the normalization of vascular iNOS content observed in trained T1DM animals (DX) 
when compared to sedentary T1DM (D).  
            Exercise stress induces an HSR which in turn helps initiate an anti-inflammatory 
milieu (3, 17).  It has been postulated that upstream overexpression of Hsp70 imposes 
downstream inhibition of iNOS and prevents the subsequent accumulation of high iNOS 
protein levels in various organ tissue lysates including brain (24, 25).  A proposed 
underlying mechanism to this Hsp70 prompted protection is Hsp70 inhibition of NF-κB 
via of its interaction with the NF-κB inhibitor I-κB.    
 With specific reference to eNOS, in this study there were no significant 
differences in eNOS protein content between groups, particularly between T1DM and 
non-T1DM groups.  In contrast to prior studies illustrating a significant decrease in eNOS 
bioactivity and accumulation in VSMCs, this study observed a minute overall decrease in 
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the T1DM groups when compared to sedentary and trained non-T1DM groups but these 
data were non-significant.  One possible explanation could be the exogenous insulin and 
attenuated degree of hyperglycemia (<20mmol) in this study, wherein the previous 
studies by Mohan et,al (37) maintained higher grade  or ‘severe’ hyperglycemia 
(>25mmol).  The collective data from iNOS and eNOS in this model of T1DM depicts a 
story whereby the progression of vascular inflammation precedes the phenotypic onset of 
endothelial dysfunction.   
 The midpoint and endpoint temperature data in brief illustrate a non-significant 
increase from pre to post temperatures in diabetic trained animals (DX) when compared 
to significant increases from pre to post observed in trained animals (CX). In addition, 
diabetic animals experienced higher pre exercise temperature measures when compared 
to their non-diabetic trained counterparts. This observation in part could explain for the 
HSP expression observed in diabetic animals in this study and could also be a factor of 
disease induced symptoms that distort thermoregulatory mechanisms. This speculative 
distortion could then have various downstream impacts on HSP expression however, the 
exact mechanisms are not clearly understood at this point.  
 The vascular signal intensity was adjusted for SMA in small and large cerebral 
vessels, in order to determine if and any potential impact of vessel size existed on the 
individual protein expression.  The SMA alone did not change between the four groups in 
small or large vessels, with factors of disease (D) and training interventions (DX, CX) 
when compared to sedentary (C).  We had examined this because previous data suggested 
that diabetes was associated with vascular hyperptrophy (4, 52).  The fact that we did not 
observe any change in SMA in the present investigation likely underscores the fact that 
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we were using a controlled low-grade hyperglycemia diabetic model rather than an 
untreated diabetic animal.  The short duration of the study, given that vascular 
hypertrophy manifests at a more progressive stage of T1DM may have also been a factor.   
Though the pattern of expression was similar in small and large vessels across all four 
proteins of interest, when adjusted for SMA, Hsp90 and eNOS signal content had a main 
effect of size. The Hsp90 and eNOS protein content was significantly greater in smaller 
vessels when compared to larger vessels, prominent more so with eNOS expression.  
These observations are similar to recently published data from our lab, where Murias et.al 
(32) demonstrated greater eNOS protein content in smaller vessels, femoral arteries, 
when compared to large branches of vessels such as the iliac artery and the descending 
branch of aorta from in trained and untrained diabetic rats (38).  In that study, a greater 
concentration of eNOS protein in smaller vessels was implicated in the faster rate of 
vasorelaxation observed in femoral when compared to the larger aorta and iliac. Hsp90 
signal density was greater in smaller vessels than larger vessels, and the size effect was 
significant, indicating that Hsp90 maintains a pattern of bioactivity parallel to that of 
eNOS in the cerebrovasculature. In addition, the SMA adjustments denote the importance 
of quantifying the signal content to area in order to gage a more normalized expression 
factoring in the size.   
 2.5 Conclusion 
 Until now, no observations exist on cerebrovascular HSP and NOS expression in 
a controlled low-grade hyperglycemic, insulin treated diabetes model and especially that, 
with chronic exercise training intervention.  The objective of this study was to evaluate 
the effect of 10-weeks of high intensity aerobic training alone and in a slightly 
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hyperglycemic T1DM condition, on HSP and NOS expression and concomitant 
localization in cerebral vessels. Although animal models have frequently been employed 
to study the effect of exercise on T1DM, the severity of hyperglycemia in those particular 
models have imposed high levels of physiological stress such that, the results are difficult 
to translate  (7).  In fact, blood glucose levels in these animals have been well above the 
normal limits observed in human patients. In the present study, we attempted to mimic a 
low level of hyperglycaemia often found in humans, even in the presence of insulin 
supplementation (34).  Hence this study has more translational relevance. 
The results supported the hypothesis that a 10-week high intensity training 
protocol would be associated with a significant increase in Hsp70 in control exercised 
animals (CX); however, this response was not attenuated or blunted as expected in the 
exercise trained diabetic group (DX). Interestingly, 10-week training protocol in the 
diabetic group significantly blunted pro-inflammatory iNOS protein content when 
compared to the increase in the pro-inflammatory iNOS observed in diabetic sedentary 
group (D).  This suggests that although many vascular properties, such as SMA, may be 
well maintained when insulin is present and hyperglycemia is moderate, markers of 
chronic cerebrovascular inflammation are still present.  Importantly, exercise training 
appears to mitigate this response even in the presence of reduced circulating insulin and 
unaltered blood glucose levels.  It is likely that elevations in vascular Hsp70 subsequent 
to exercise training may protect against the progression of atherosclerosis and potentially 
stroke by inhibiting iNOS and subsequent vascular inflammation (17, 54). This warrants 
further study into the direct interactions between Hsp70 and pro-inflammatory regulators, 
in order to address and advance towards potential therapeutic strategies.  
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The results for Hsp90 and eNOS are in not in concurrence with our hypothesis, in 
that there were no significant differences in vascular Hsp90 and eNOS protein content 
amongst groups.  We speculate that this can be attributed to an intrinsically tight cerebral 
autoregulation that strives to keep vasodilatory mechanisms stable in addition to the 
model of T1DM implemented in this translational approach.   The outcomes of this study 
have touched upon the HSP expression underlying exercise induced vascular protection 
and merits future investigations in HSR regulation that can be translated into 
interventions in chronic diseases that include components of cerebral vascular pathology.  
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CHAPTER 3 
3.1 Limitations and Assumptions 
This study sought to investigate a unique concept of cerebrovascular HSP and 
NOS expression, whereby the novelty of the subject made it difficult to interpret all 
results with complete assurance. This is mostly due to the lack of previous studies 
implementing a more physiological T1DM model, such as this study whereby exogenous 
insulin therapy afforded a more controlled low-grade hyperglycemia.    In addition,  there 
exists a  lack of interventions examining chronic high intensity exercise training alone 
and in a T1DM model, on cerebrovascular HSP and NOS expression.   
Having said that, there are considerations that could reinforce the results and these 
considerations include directed characterization of molecular regulators and client 
proteins of the HSPs studied.  In particular, the speculative discussion around Hsp70 and 
iNOS could be clarified with characterization of intermediate regulators, including NF-
κβ, I-κβ and TNFα.   A closer look at the molecular interactions, perhaps in situ 
hybridization or immunoprecipitation assay protocols could highlight more precise  
interactions between Hsp70 and the aforementioned pro-inflammatory regulators.   In 
effect these assays would bolster the speculations about the anti-inflammatory role of 
Hsp70  interactions with downstream factors, including in this study iNOS. By extension, 
evaluating direct interactions between Hsp90 and its clients, including  eNOS,  IKKβ by 
means of immunoprecipitation assays could highlight how this housekeeping protein 
regulates between disease and non-disease states. 
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Recent applications of in vivo research has shifted towards genetic manipulations 
that target studying specific proteins of interest through transgenic knock out and knock 
down models.   The  transgenic knockout/knockdown or overexpression of (Hsp70+/-), 
(Hsp70 -/-) in recent studies have elucidated many regulatory functions of Hsp70 and 
future studies could potentially investigate and extract the precise role of Hsp70 in this 
model and clarify if Hsp70 is a primary player in the observed neuroprotection.    
The experimental results are speculations that could be bolstered with cerebral 
blood flow (CBF) measures which were not taken into account for the experiment design 
in this study.  CBF measures could potentially shed light on the functional changes, 
particular following exercise training and the response to lower grade hyperglycemia in 
the cerebrovascular setting.  CBF data would contribute to elucidating the flow mediated 
influence on vascular shifts that would better explain the observed results, particularly 
with Hsp90 and eNOS.  
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APPENDIX A 
A1. Streptozotocin induction protocol 
             REVISION DATE: 13/06/2012 
 
PURPOSE: 
To induce Type I diabetes in rats 
 
MATERIALS: 
Gloves 
Lab Coat 
Streptozotocin (STZ) 
5X Stock Citric Acid/Citrate Buffer  
- Anhydrous Citric Acid 
- Sodium Citrate Dihydrate 
- MilliQ Deionized Water 
13M HCl 
3 Falcon Tube 
Sterile Filter 
 
EQUIPMENT: 
Biological Safety Cabinet 
Weigh Scale 
pH Meter 
 
PROCEDURE: 
Preparing 5X Citric Acid/Citrate Buffer 
1. For a pH 4.6 buffer at 765 mM (5X stock solution), in a beaker, Add 
i. 13.8g Anhydrous Citric Acid (Sigma) or 15.1g Citric Acid Monohydrate 
ii. 23.8g Sodium Citrate Dihydrate (Sigma) 
Mix into    iii.   175mL of MilliQ water 
The pH should be at 4.6, Add HCl or NaOH to adjust (do not over-shoot pH) 
2. Once the proper pH is obtained, add MilliQ water until you are close to the 200 ml 
mark (pH will move slightly).  If satisfied with the pH, adjust volume in a 250 ml 
graduated cylinder and filter in a 0.2µm filter. 
 
3. Store at room temperature.  This is your 5X stock solution. 
 
Making up Streptozotocin (STZ) for Injection 
**NOTE Animals should be pre-weighed prior to making up STZ to ensure accurate 
amounts of STZ to be prepared. 
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1. Using pre-made buffer, put 1 mL of buffer in a 50 mL Falcon Tube and add 4 mL of 
distilled water filtered through a 0.2µm syringe filter.  Check the pH.  This gives you 
a working concentration of 153 mM 
 
2. The desired pH is between 4.5-4.7.  Under the fume hood, add 1 drop at a time of 
concentrated HCl to the buffer, checking pH in between until desired pH is reached.     
 
3. Once pH is reached, add 1 mL distilled water (sterile filtered through a 0.2µm syringe 
filter as before).  If pH is below 4.5, restart. 
 
4. Weigh out an appropriate amount of STZ for the number of animals (see calculations 
below) that will be injected in a 15 minute time frame. 
 
 
Ex. Rats will be injected at 20mg/kg, so for 10 animals at an ideal weight of 200g 
(avg. weight of rats to be injected), you will require a minimum of 40mg.  
  20mg/kg X 0.2kg = 4mg per animal 
The amount of STZ weighed out should be more than the minimum as some solution 
will be lost in filtering. (4mg (per animal) X 12 rats = 48mg total (0.048g) 
5. Dissolve the STZ into buffer (keeping in mind a comfortable injection volume).  
Shake to dissolve powder (approx. 1min).  Sterile filter using a 0.2µm syringe filter.   
Ex. 48mg STZ ÷ 3 mL buffer = 16mg/mL solution 
 4mg ÷ 16mg/mL solution = 0.25mL 
6. STZ is time dependent and must be used within 5 minutes 
 
Injecting and Follow-Up of the Animals 
1. Promptly inject each rat with the solution (intraperitoneal) at a dosage rate of 
20mg/mL (in this example, 0.25mL).  Do not use anymore STZ solution more than 5 
minutes after it has been dissolved in the sodium citrate buffer. 
 
2. Dispose of any container having come into contact with the STZ (in either powder or 
dissolved form) into a biohazardous waste receptacle.  Dispose of needles into a 
sharps container. 
 
3. Return injected rats to their cage.  Record the date of STZ injection and add a 
biohazard label to the cage (leave biohazard label on cage for at least 3 days 
following the last injection). 
 
4. Repeat this procedure the following day. 
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5. Check blood glucose daily.  Diabetes is achieved with two non-fasting blood glucose 
readings of >18 mmol  Diabetes should be achieved after 5-8 injections (i.p. 
20mg/kg). 
 
Reference: 
Low dose STZ induction protocol. Animal Models of Diabetic Complications 
Consortium AMDCC Protocols.2003 
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A2. Subcutaneous insulin pellet protocol 
REVISION DATE: 13/06/2012 
 
MATERIALS: 
LinShin LinPlant Insulin Pellet 
Rat anesthetic - Isoflurane 
Ampicillin 
Sterile water 
1ml syringe with 25 g needle 
10% providone-iodine solution 
gauze (or swab) 
Tissue forceps 
Scalpel handle and blades (or scissors) 
Silk suture 
Needle drivers 
 
EQUIPMENT: 
Isofluorane Anaesthetic Machine 
Hair clippers 
Heat lamp 
 
Special Safety: 
Individual must wear lab coat and gloves before handling rodents.  Any bite or scratch 
that breaks the skin must be thoroughly scrubbed with soap and water (report to 
Occupational Health and Safety, UWO). 
 
PROCEDURE: 
Pellet implantation (for a rat): 
1. Anesthetize the animal using the isofluorane machine by placing it in the induction 
chamber. Set isoflurane to 4-5% with an O2 flow rate of 1L/min. Open the stopcock 
valve so gas reaches the chamber.  Keep in chamber until the animal is unconscious. 
2. Remove the animal and place its nose in the nose cone, reduce the isofluorane to 3% 
to maintain the plane of anesthesia.   
3. Shave the area where the pellet is to be implanted.  
4. Using gauze (or a swab), apply 10% providone-iodine solution to the skin, followed 
by 70% ethanol, to disinfect the site of insertion. 
5. Hold the skin with forceps and make a subcutaneous incision. 
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6. Cleanse a 12g trocar with 10% providone-iodine solution and insert it through the 
puncture site to a depth of at least 2 cm. 
7. Using forceps, briefly immerse the pellet in 10% providone-iodine solution, rinse 
with saline and insert into the subcutaneous region.  
8. Use 1 pellet for the first 350g of body weight.  
9. Pinch the skin closed after the last pellet is inserted. Place a drop of 10 % providone-
iodine solution over the opening.  
10. Close the incision by suturing. 
11. Place the animal under a heat lamp and monitor until it recovers from anesthesia. 
12. Record on the cage card that insulin pellets have been implanted.  
Pellet removal: 
1. Anesthetize the animal as described above for implantation.  
2. Shave and palpate the area of implantation to locate pellets. Sterilize this area by 
applying 10% providone-iodine solution followed by 70% ethanol. 
3. Using a scalpel (or scissors), make an incision through the skin superficial to the 
location of the pellets.  
4. Using forceps, remove the pellet. Some connective tissue may need to be cut away 
using scissors. Discard the pellet. 
5. Close the incision by suturing.  
6. Place the animal under a heat lamp and monitor until it recovers from anesthesia. 
7. Record on the cage card that the pellets have been removed. 
 
References: 
http://www.linshincanada.com  
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A3. Brain Histology and Orientation 
 
 
 
 
 
 
 
 
 
 
 
A.3 Sagittal Section of the Rat Brain 
Dashed lines illustrate the approximate location of initial transverse 
sectioning of whole brains(17).  
A.3 Transverse Section of the Rat rain. 
The adapted image illustrates a prototype of the IHC sections.  
Red dashed circles enclose area indicating the area of cerebral blood 
vessel observation(19). 
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A4. Histochemical Stains 
 
 
Histological Visualization of Cerebral Vessels in H & E and LXFB across a spectrum of 
magnification illustrates the anatomical region of cerebral vessels and delineates a small 
cerebral vessel from a large cerebral vessel. It further delineates cerebral matter from the 
adjacent vessels 
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A5.Fluorescent Structural Comparison of Large versus Small Cerebral Vessels 
 
 
 
For the purpose of the study, the vessels were separated into two sizes by their diameter 
and their morphological appearance.  The larger vessels were identified as arterioles that 
encompassed 2-3 layers of smooth muscle cells and maintained a diameter range of about 
0.135-0.14mm.  The smaller vessels were identified as terminating arterioles with 
roughly a single layer of smooth muscle and maintained a diameter range of about 0.04-
0.05mm.  
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A6. Immunofluorescence Localization Protocol 
REVISION DATE: 19/6/2013 
Proteins tested: Hsp70, Hsp90, iNOS, eNOS 
Tissue tested: Paraffinized brain tissue: 
Tissue Preparation:  
Whole brains were extracted 72 hours post-last exercise training bout for trained or 
following 10-week sedentary window.   
Following which, brains were immediately placed in 4% paraformaldehyde renewed 
daily for 72 hours and placed in 70% ethanol until tissue processing.   
Brain tissues were transversally split-sectioned and embedded in paraffin, 10µm  
transverse sections were mounted as pairs on  frosted, poly-L-Lysine-coated, positively 
charged microscope slides and stored at room temperature. Each slide held two serial 
sections of the tissue in order to have negative controls.  
Immunofluorescent (IHC) 
IHC Day 1 
1. Deparaffinize slides and antigen retrieved for approximately two hours with sodium 
citrate buffer [10mM sodium citrate, 0.05% tween-20, pH 6.0] 
 
2. Transfer slides to coplin jars and wash in 0.01% Tween-20 in PBS (T-PBS) for 5 
minutes, followed by two washes in phosphate buffered saline (PBS, 1M) for 5 
minutes each. 
 
3. Following the washes dry slides with Kimwipe and double circle each tissue section 
on the slide with a grease pen. 
 
4. Block sections at room temperature with 10% goat serum in PBS for 1 hour in 
humidity chambers 
In the meantime, primary antibodies were thawed at room temperature and 
assembled as cocktail dilutions of in 1% Tween-PBS (TPBS) goat serum. 
 
5. The primary antibodies were combined as follows: 
Hsp70: Rabbit polyclonal anti-hsp72 (SPA-812 StressGen) +  mouse monoclonal 
anti-alpha smooth muscle (ABCAM-18147). 
Hsp90: Rabbit polyclonal to hsp90 (ABCAM-13495) +  mouse monoclonal anti-
alpha smooth muscle (ABCAM-18147). 
iNOS: Rabbit polyclonal anti-iNOS (ABCAM-15323) + mouse monoclonal anti-
alpha smooth muscle (ABCAM-18147). 
eNOS: Rabbit polyclonal anti-eNOS/NOS Type III (BD Biosciences-610299) + 
mouse monoclonal anto-alpha smooth muscle (ABCAM-18147). 
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1° Antibody 
Cocktails 
Antibody Identifier 1° Antibody Concentration 
Hsp70 + Smooth 
Actin 
Hsp70 (SPA-812) 1:100 
Smooth α actin (AB18147) 1:400 
Hsp90 + Smooth 
Actin 
Hsp90 (AB13485) 1:400 
Smooth α actin (AB18147) 1:400 
iNOS + Smooth 
Actin 
iNOS (AB 15323) 1:100 
Smooth α actin (AB18147) 1:400 
eNOS + Smooth 
Actin 
eNOS 1:100 (BD610299) 1:100 
Smooth α actin (AB18147) 1:400 
 
 
6. Following block, wash slides in PBS for three cycles of 5 minutes increment and dry 
with Kimwipes.  One out of two possible tissue sections on every slide incubate with 
primary antibodies overnight in 4°celsius. The other section was incubated with 1% 
TPBS goat serum in absence of primary antibodies in order to function as negative 
controls to test for non-specific staining. 
IHC Day 2:  
7. Wash slides in PBS for three cycles of 5 minute increment and dry with Kimwipes, 
following which incubate all sections secondary antibodies for 1 hour at room 
temperature.  
 
8. Make secondary Antibody Cocktail: Anti-mouse (1:400) + anti-rabbit secondary 
(1:400) antibodies in 1% goat serum in T-PBS 
 
2°  Antibody Cocktail 
Constituents 
Antibody Identifier 2°  Antibody 
Concentration 
Anti-mouse 
 (Green fluorescence) 
Alexa Fluor®488 Goat 
Anti-Mouse IgG, 
Invitrogen, 
1:400 
Anti-rabbit 
(Red fluorescence) 
Alexa Fluor®594 Goat 
Anti-Rabbit IgG, 
Invitrogen 
1:400 
 
 
9. Following secondary incubation, wash slides in PBS for three cycles (5 minute 
increments) and dry with Kimwipes.   
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10. For the purpose of fluorescent imaging, mount slides with a fluorescent mounting 
medium (Prolong® Gold Antifade Reagent containing DAPI, Invitrogen) containing 
1% 4’, 6-diamidino-2-phenylindole (DAPI), a fluorescent nuclear stain and then 
covered with glass cover slips (VWR® SuperSlips™ Micro Cover Glasses, 
Rectangular, No. 1, 24 X 55mm, CA48382-128). In order to maintain the fluorescent 
signal integrity and minimize photo bleaching, the store slides in a slide folder at 4˚C 
until imaging.  
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A7. Protein Abundance Acquisition   
REVISION DATE: 19/06/2013 
 
1. The fluorescent bright field microscopy carried out on (Zeiss Axiovert S100) and 
images were captured on Axiovert S100 at 16X and 40X magnification, using Northern 
Eclipse 6.0  (Empix Imaging Inc) software. 
 
2. The protein content/abundance signal for Hsp70, Hsp90, iNOS and eNOS were 
extracted as using Image J. Specifically, protein content was determined by outlining the 
blood vessel of interest (D) and calculating the integrated pixel density (signal) using the 
selection brush (B), on Image J and the same technique was used to determine the 
integrated pixel density for the negative control of the same blood vessel.  
 
3. To obtain the relative protein density, the pixel density of the negative control was 
subtracted from the pixel density of the experimental sample. The difference in pixel 
density provided values that were used to indicate fluorescence signal intensity and thus 
quantity of protein. For the collection of data for small and large vessels, this mode was 
repeated for four blood vessels from the same animal and averaged to give a signal 
protein value for the particular animal.  
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A8.Smooth Muscle Area Calculations 
For comparative analysis between vessel size and protein content, smooth muscle area 
(SMA) was calculated for each vessel where the protein content was calculated. In 
addition, SMA calculations allowed for protein content adjusted to the area.  
The measures were collected from Image J. (A-B) 
 
For SMA calculations, two full length perpendicular diameters from the outer perimeter 
of each vessel (C) were averaged to obtain a diameter for the outer circle.  Likewise, two 
perpendicular diameters from the inner ‘endothelial’ perimeter of each vessel were 
averaged to obtain a diameter for the inner circle(D). Both the diameters were 
implemented to manually calculate the respective circular areas(E,F).  The smaller circle 
area (F) was then subtracted from the larger(E) circle in order to obtain the SMA for that 
specific vessel(G). 
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